These factors could provide a scientific basis for consistency evaluations of the quality and efficacy of insulin biosimilars, study authors wrote. Factors that may affect the bioequivalence of test ...

Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir. (Insulin glargine has US Food and Drug Administration [FDA] ...

New research suggests that a large portion of a diabetic's insulin dose is unlikely to work as expected. University of Copenhagen researchers have discovered that we have miscalculated insulin ...

Regular (R) insulin is a short-acting, injectable insulin used for the management of diabetes. It is typically taken before meals to prevent glucose from rising after a person eats. Regular insulin is ...

Cadenas, E., Kaji, H., Park, C. R., and Basmussen, H., J. Biol. Chem., 236, PC 63 (1961). Clauser, H., Volfin, P., Eboué-Bonis, D., and Chambaut, A. M ...

Thus, evidence supports a logical hypothesis: In patients who are early in their natural histories and already have prediabetes, 1) identifying the problem at such an early stage, and 2) keeping ...

Diabetes requires an extremely precise form of daily treatment, whereby patients have to inject themselves with several doses of insulin every day, which are suited to their diet and physical activity ...

Over 30 million Americans have diabetes, and more than 7 million of them require daily insulin. But the cost of the drug has risen considerably in the last decade. Though U.S. lawmakers are ...

Waltham: Thermo Fisher Scientific Inc., has unveiled the Gibco Efficient-Pro Medium (+) Insulin, a next-generation medium ...